Cargando…

Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning

The Ki‐67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki‐67 PI requires calculation of Ki‐67‐positive and Ki‐67‐negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning‐based Ki‐67 PI alg...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesterinen, Tiina, Säilä, Jenni, Blom, Sami, Pennanen, Mirkka, Leijon, Helena, Arola, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299468/
https://www.ncbi.nlm.nih.gov/pubmed/34741788
http://dx.doi.org/10.1111/apm.13190
_version_ 1784750982406602752
author Vesterinen, Tiina
Säilä, Jenni
Blom, Sami
Pennanen, Mirkka
Leijon, Helena
Arola, Johanna
author_facet Vesterinen, Tiina
Säilä, Jenni
Blom, Sami
Pennanen, Mirkka
Leijon, Helena
Arola, Johanna
author_sort Vesterinen, Tiina
collection PubMed
description The Ki‐67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki‐67 PI requires calculation of Ki‐67‐positive and Ki‐67‐negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning‐based Ki‐67 PI algorithm (KAI) that objectively calculates Ki‐67 PI. Our study material consisted of NETs divided into training (n = 39), testing (n = 124), and validation (n = 60) series. All slides were digitized and processed in the Aiforia(®) Create (Aiforia Technologies, Helsinki, Finland) platform. The ICC between the pathologists and the KAI was 0.89. In 46% of the tumors, the Ki‐67 PIs calculated by the pathologists and the KAI were the same. In 12% of the tumors, the Ki‐67 PI calculated by the KAI was 1% lower and in 42% of the tumors on average 3% higher. The DL‐based Ki‐67 PI algorithm yields results similar to human observers. While the algorithm cannot replace the pathologist, it can assist in the laborious Ki‐67 PI assessment of NETs. In the future, this approach could be useful in, for example, multi‐center clinical trials where objective estimation of Ki‐67 PI is crucial.
format Online
Article
Text
id pubmed-9299468
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92994682022-07-21 Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning Vesterinen, Tiina Säilä, Jenni Blom, Sami Pennanen, Mirkka Leijon, Helena Arola, Johanna APMIS Original Articles The Ki‐67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki‐67 PI requires calculation of Ki‐67‐positive and Ki‐67‐negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning‐based Ki‐67 PI algorithm (KAI) that objectively calculates Ki‐67 PI. Our study material consisted of NETs divided into training (n = 39), testing (n = 124), and validation (n = 60) series. All slides were digitized and processed in the Aiforia(®) Create (Aiforia Technologies, Helsinki, Finland) platform. The ICC between the pathologists and the KAI was 0.89. In 46% of the tumors, the Ki‐67 PIs calculated by the pathologists and the KAI were the same. In 12% of the tumors, the Ki‐67 PI calculated by the KAI was 1% lower and in 42% of the tumors on average 3% higher. The DL‐based Ki‐67 PI algorithm yields results similar to human observers. While the algorithm cannot replace the pathologist, it can assist in the laborious Ki‐67 PI assessment of NETs. In the future, this approach could be useful in, for example, multi‐center clinical trials where objective estimation of Ki‐67 PI is crucial. John Wiley and Sons Inc. 2021-11-22 2022-01 /pmc/articles/PMC9299468/ /pubmed/34741788 http://dx.doi.org/10.1111/apm.13190 Text en © 2021 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Medical Microbiology and Pathology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Vesterinen, Tiina
Säilä, Jenni
Blom, Sami
Pennanen, Mirkka
Leijon, Helena
Arola, Johanna
Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
title Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
title_full Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
title_fullStr Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
title_full_unstemmed Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
title_short Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
title_sort automated assessment of ki‐67 proliferation index in neuroendocrine tumors by deep learning
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299468/
https://www.ncbi.nlm.nih.gov/pubmed/34741788
http://dx.doi.org/10.1111/apm.13190
work_keys_str_mv AT vesterinentiina automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning
AT sailajenni automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning
AT blomsami automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning
AT pennanenmirkka automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning
AT leijonhelena automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning
AT arolajohanna automatedassessmentofki67proliferationindexinneuroendocrinetumorsbydeeplearning